192 related articles for article (PubMed ID: 24580550)
1. miRNA as markers for the diagnostic screening of colon cancer.
Ahmed FE
Expert Rev Anticancer Ther; 2014 Apr; 14(4):463-85. PubMed ID: 24580550
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle.
Ahmed FE; Ahmed NC; Vos PW; Bonnerup C; Atkins JN; Casey M; Nuovo GJ; Naziri W; Wiley JE; Mota H; Allison RR
Cancer Genomics Proteomics; 2013; 10(3):93-113. PubMed ID: 23741026
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic microRNA markers to screen for sporadic human colon cancer in blood.
Ahmed FE; Amed NC; Vos PW; Bonnerup C; Atkins JN; Casey M; Nuovo GJ; Naziri W; Wiley JE; Allison RR
Cancer Genomics Proteomics; 2012; 9(4):179-92. PubMed ID: 22798503
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic microRNA markers for screening sporadic human colon cancer and active ulcerative colitis in stool and tissue.
Ahmed FE; Jeffries CD; Vos PW; Flake G; Nuovo GJ; Sinar DR; Naziri W; Marcuard SP
Cancer Genomics Proteomics; 2009; 6(5):281-95. PubMed ID: 19996134
[TBL] [Abstract][Full Text] [Related]
5. Transcriptomic molecular markers for screening human colon cancer in stool and tissue.
Ahmed FE; Vos P; iJames S; Lysle DT; Allison RR; Flake G; Sinar DR; Naziri W; Marcuard SP; Pennington R
Cancer Genomics Proteomics; 2007; 4(1):1-20. PubMed ID: 17726236
[TBL] [Abstract][Full Text] [Related]
6. RT-qPCR for Fecal Mature MicroRNA Quantification and Validation.
Ahmed FE; Ahmed NC; Gouda MM; Vos PW; Bonnerup C
Methods Mol Biol; 2018; 1765():203-215. PubMed ID: 29589310
[TBL] [Abstract][Full Text] [Related]
7. Fecal miR-106a is a useful marker for colorectal cancer patients with false-negative results in immunochemical fecal occult blood test.
Koga Y; Yamazaki N; Yamamoto Y; Yamamoto S; Saito N; Kakugawa Y; Otake Y; Matsumoto M; Matsumura Y
Cancer Epidemiol Biomarkers Prev; 2013 Oct; 22(10):1844-52. PubMed ID: 23950216
[TBL] [Abstract][Full Text] [Related]
8. Gene expression analysis using a highly sensitive DNA microarray for colorectal cancer screening.
Koga Y; Yamazaki N; Takizawa S; Kawauchi J; Nomura O; Yamamoto S; Saito N; Kakugawa Y; Otake Y; Matsumoto M; Matsumura Y
Anticancer Res; 2014 Jan; 34(1):169-76. PubMed ID: 24403458
[TBL] [Abstract][Full Text] [Related]
9. Identification of microRNA-135b in stool as a potential noninvasive biomarker for colorectal cancer and adenoma.
Wu CW; Ng SC; Dong Y; Tian L; Ng SS; Leung WW; Law WT; Yau TO; Chan FK; Sung JJ; Yu J
Clin Cancer Res; 2014 Jun; 20(11):2994-3002. PubMed ID: 24691020
[TBL] [Abstract][Full Text] [Related]
10. Clinical performance of an automated stool DNA assay for detection of colorectal neoplasia.
Lidgard GP; Domanico MJ; Bruinsma JJ; Light J; Gagrat ZD; Oldham-Haltom RL; Fourrier KD; Allawi H; Yab TC; Taylor WR; Simonson JA; Devens M; Heigh RI; Ahlquist DA; Berger BM
Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1313-8. PubMed ID: 23639600
[TBL] [Abstract][Full Text] [Related]
11. Fecal MicroRNAs as novel biomarkers for colon cancer screening.
Link A; Balaguer F; Shen Y; Nagasaka T; Lozano JJ; Boland CR; Goel A
Cancer Epidemiol Biomarkers Prev; 2010 Jul; 19(7):1766-74. PubMed ID: 20551304
[TBL] [Abstract][Full Text] [Related]
12. Molecular markers for human colon cancer in stool and blood identified by RT-PCR.
Ahmed FE; Vos P
Anticancer Res; 2004; 24(6):4127-34. PubMed ID: 15736463
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive screening tests for colorectal cancer.
Imperiale TF
Dig Dis; 2012; 30 Suppl 2():16-26. PubMed ID: 23207928
[TBL] [Abstract][Full Text] [Related]
14. [Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening?].
Quintero E
Gastroenterol Hepatol; 2009 Oct; 32(8):565-76. PubMed ID: 19577340
[TBL] [Abstract][Full Text] [Related]
15. Colon cancer screening: which non-invasive filter tests?
Pox C
Dig Dis; 2011; 29 Suppl 1():56-9. PubMed ID: 22104755
[TBL] [Abstract][Full Text] [Related]
16. DNA methylation biomarkers of stool and blood for early detection of colon cancer.
Hong L; Ahuja N
Genet Test Mol Biomarkers; 2013 May; 17(5):401-6. PubMed ID: 23406208
[TBL] [Abstract][Full Text] [Related]
17. Stool test for colorectal cancer screening--it's time to move!
Loitsch SM; Shastri Y; Stein J
Clin Lab; 2008; 54(11-12):473-84. PubMed ID: 19216253
[TBL] [Abstract][Full Text] [Related]
18. Standardization for transcriptomic molecular markers to screen human colon cancer.
Ahmed FE; Vos PW; Ijames S; Lysle DT; Flake G; Sinar DR; Naziri W; Marcuard SP
Cancer Genomics Proteomics; 2007; 4(6):419-31. PubMed ID: 18204205
[TBL] [Abstract][Full Text] [Related]
19. Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test.
Vilkin A; Rozen P; Levi Z; Waked A; Maoz E; Birkenfeld S; Niv Y
Am J Gastroenterol; 2005 Nov; 100(11):2519-25. PubMed ID: 16279909
[TBL] [Abstract][Full Text] [Related]
20. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
